Need professional-grade analysis? Visit stockanalysis.com
$140.68B
111.52
N/A
N/A
AGARWALEYE (AGARWALEYE) trades on NSE in INR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at INR444.05, down 0.76% from the previous close.
Over the past year, AGARWALEYE has traded between a low of INR334.05 and a high of INR545.70. The stock has gained 12.3% over this period. It is currently 18.6% below its 52-week high.
AGARWALEYE has a market capitalization of $140.68B, with a price-to-earnings ratio of 111.52.
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.
Side-by-side comparison against top Healthcare peers.